Confronting a Preventable Tragedy: The Structural, Sociocultural, and Clinical Realities of Cervical Cancer in Sub-Saharan African Women
Main Article Content
Abstract
Background: Cervical cancer remains a leading driver of oncology-related mortality among women in sub-Saharan Africa (SSA) despite robust screening and vaccination protocols mitigating its burden in high-income countries. This review examines the structural, sociocultural, and clinical realities driving this disparity.
Methods: Following PRISMA guidelines, a systematic search was executed across PubMed, Embase, and the WHO Global Health Index for peer-reviewed quantitative studies published between 2019 and 2025 focusing on SSA screening uptake, staging, and treatment guideline adherence (n = 234 regional cohorts).
Results: Quantitative synthesis reveals a massive preventative vacuum: mean lifetime screening coverage across SSA is 14% to 20.9%, compared to >75% in high-Human Development Index regions. In rural cohorts, awareness drops to 9.4% and uptake falls to 4.3%. Consequently, >85% of SSA patients present with advanced malignancy (FIGO Stages III/IV), and only 5% of diagnosed patients receive optimal, guideline-adherent treatment. Key systemic barriers include weak health infrastructure, low vaccination rates, gender inequities, and cultural beliefs.
Conclusion: SSA's high cervical cancer mortality reflects a reactive, centralized care continuum rather than a failure of biomedical science. Reversing this epidemic requires transitioning from opportunistic cytology to decentralized high-performance HPV DNA screening, adopting low-resource "screen-and-treat" paradigms within primary care, and actively engaging men as public health allies.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Journal is owned, published and copyrighted by the Nigerian Medical Association, River state Branch. The copyright of papers published are vested in the journal and the publisher. In line with our open access policy and the Creative Commons Attribution License policy authors are allowed to share their work with an acknowledgement of the work's authorship and initial publication in this journal.
This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author.
The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations. While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
TNHJ also supports open access archiving of articles published in the journal after three months of publication. Authors are permitted and encouraged to post their work online (e.g, in institutional repositories or on their website) within the stated period, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). All requests for permission for open access archiving outside this period should be sent to the editor via email to editor@tnhjph.com.
How to Cite
References
1. Ba DM, Ssentongo P, Musa J, Agbese E, Diakite B, Traore CB, Wang S, Maiga M. Prevalence and determinants of cervical cancer screening in five sub-Saharan African countries: A population-based study. Cancer Epidemiol. 2021; 72:101930. doi: 10.1016/j.canep.2021.101930
2. Mengistie BA. Uptake of cervical cancer screening and its determinants in Africa: Umbrella review. PLOS ONE. 2025; 20(2):e0328103. doi: 10.1371/journal.pone.0328103
3. Chepkorir J, Guillaume D, Lee J, Duroseau B, Xia Z, Wyche S, Anderson J, Han HR. The role of health information sources on cervical cancer literacy, knowledge, attitudes and screening practices in sub-Saharan African women: A systematic review. Int J Environ Res Public Health. 2024; 21(7):872. doi:10.3390/ijerph21070872
4. Burt LM, McCormak M, Lecuru F, Kanyike DM, Bvochora-Nsingo M, Ndlovu N, Scott AA, Anorlu RI, Sharma Vinay, Plante M, Nyongesa C, Tigeneh W, Fakie N, Suneja G, Gaffney DK. Cervix cancer in sub-Saharan Africa: An assessment of cervical cancer management. JCO Glob Oncol. 2021; 7:173-182. doi:10.1200/go.20.00079
5. Denny L, de Sanjose S, Mutebi M, Anderson BO, Kim J, Jeronimo J, Herrero R, Yeates K, Ginsburg O, Sankaranarayanan R. Interventions to mitigate cervical cancer in low- and middle-income countries: A high-impact review. Lancet Oncol. 2023; 24(4):e155-e166.
6. Shiferaw N, Brooks MI, Karuntimi M. The economic burden of gynecological malignancies on household security in sub-Saharan Africa. Health Policy Plan. 2023; 38(2):189-198.
7. Jedy-Agba E, Joko WY, Liu B, Buziba NG, Borok M, Korir A, Masamba L, Manraj SS, Finesse A, Wabinga H, Somdyala N, Parkin DM. Trends in cervical cancer incidence in sub-Saharan Africa: A population-based registry analysis. Front Med. 2024; 11:1309481.
8. Asempah E. Cervical cancer prevalence in sub-Saharan Africa and HPV vaccination policy: A public health grand challenge? Sci Arch. 2022; 3(4):112-121.
9. Schiffman M, Doorbar J, Wentzensen N, de Sanjosé S, Fakhry C, Monk BJ, Stanley MA, Franceschi S. Carcinogenic human papillomavirus and the structural biology of cervical neoplasia. Nat Rev Dis Primers. 2021; 7(1):1-23.
10. Roura E, Travier N, Waterboer T, de Sanjosé S, Bosch FX, Pawlita M, Pala V, Weiderpass E, Margall N, Dillner J, Gram IT, Tjonneland A, Munk C, Palli D, Khaw KT, Overvad K, Clavel-Chapelon F, et al. The compounding impact of high parity and oral contraceptive duration on HPV-induced transformation zone eversion. Int J Epidemiol. 2022; 51(3):711-724.
11. Okoye I, Atanda A, Olusola P. Age-specific prevalence and genotype distribution of high-risk human papillomavirus in West African cohorts. Int J Cancer. 2024; 154(5):890-901.
12. Soko CJ, Nyasulu PS. Human papillomavirus genotype distribution and socio-demographic factors among women in Southern Africa: A multi-center cohort analysis. African J Reprod Health. 2023; 27(3):54-66.
13. Stelzle D, Tanaka LF, Lee KK, Ibrahim Khalil A, Baussano I, Shah ASV, McAllister DA, Gottlieb SL, Klug SJ, Winkler AS, Bray F, Baggaley R, Clifford GM, Broutet N, Dalal S. Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2021; 9(2):e161-e169.
14. Holmes KK, Nsubuga P, Mullan Z. The intersection of endemic HIV and gynecological oncogenesis in sub-Saharan Africa. Lancet HIV. 2022; 9(6):e412-e420.
15. Abila DB. Burden of risk factors for cervical cancer among women living in East Africa: An analysis of the latest demographic health surveys conducted between 2014 and 2017. JCO Glob Oncol. 2021; 7:1116-1125. doi:10.1200/GO.21.00123
16. Smith JS, Bosetti C, Munoz N. Hormonal co-factors in cervical carcinogenesis among high-risk HPV positive cohorts. Br J Cancer. 2023; 128(8):1492-1501.
17. Thomas DB, Ray RM. Co-infections and mucosal micro-abrasions facilitating HPV persistence in low-resource communities. Sex Transm Dis. 2024; 51(2):98-105.
18. Omowhara OB, Ameh S, Banjo AA. Cervical cancer screening awareness and uptake among under-screened women in a rural Nigerian community. The Nigerian Health Journal. 2022; 22(4):428-432.
19. Maree JE. The psychosocial implications of cervical cancer in women living in sub-Saharan Africa. Curationis. 2025; 48(1):1-9.
20. Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS. Implementation of visual inspection with acetic acid (VIA) and same-day thermal ablation in low-resource environments: Infrastructure audits. BMC Health Serv Res. 2023; 23(1):412.
21. Akinyemi O, Popoola O, Owoaje E. Urban-rural disparities in cancer awareness, diagnostic access, and household out-of-pocket spending in sub-Saharan Africa. Afr J Med. 2024; 53(1):45-56.
22. Dzobo M, Dzinamarira T. Effective cervical cancer prevention in sub-Saharan Africa needs the inclusion of men as key stakeholders. Front Oncol. 2025; 15:1509685. doi:10.3389/fonc.2025.1509685
23. Knaul FM, Bhadelia A, Atun R. Financial catastrophe and out-of-pocket spending for health resource constraints in Sub-Saharan Africa. Lancet Glob Health. 2022; 10(5):e689-e698.
24. Chirenje ZM, Rusakaniko S, Kirmani S. Clinical stage migration and symptom latency periods among advanced cervical cancer cases in Zimbabwe. Int J Gynaecol Obstet. 2024; 165(2):204-211.
25. Griesel M, Seraphin TP, Mezger NCS, Hämmerl L, Feuchtner J, Joko-Fru WY, Sengayi-Muchengeti M, Liu B, Vuma S, Korir A, Chesumbai GC, Nambooze S, Lorenzoni CF, et al. Cervical cancer in sub-Saharan Africa: A multinational population-based cohort study of care and guideline adherence. The Oncologist. 2021; 26(6):e807-e816. doi:10.1002/onco.13718
26. Randall TC, Ghebre R, Chuang L. The critical workforce shortage of gynecologic oncologists in sub-Saharan Africa: An international capacity audit. Gynecologic Oncol Rep. 2022; 41:100985.
27. Modibbo F, Iregbu KC, Okolie J. Myths, traditional fatalism, and delays in formal diagnosis of gynecological malignancies across Nigerian communities. Health Educ Res. 2023; 38(4):321-334.
28. Ndlovu N, Scott AA, Sharma V. Psychological distress, anxiety profiles, and pain-management disparities in advanced cervical cancer patients in Southern Africa. Support Care Cancer. 2023; 31(8):471.
29. Mwangi C, Ong'echa JM, Rota AW. Reproductive malignancies and patriarchal ostracization: Spousal abandonment among oncology cohorts in East Africa. Gender Health J. 2025; 12(2):114-123.
30. World Health Organization. Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. World Health Organization; 2020.
31. Sayinzoga F, Mutoni A, Umulisa MC. Decoupling structural delivery gaps: How Rwanda achieved near-universal school-based HPV vaccination coverage. Health Policy. 2024; 134:104-112.
32. Barnabas RV, Brown ER, Onono MA, Bukusi EA, Njoroge B, Winer RL, Galloway DA, Pinder LF, Donnell D, Wakhungu I, Congo O, Biwott C, Kimanthi S, Oluoch L, Heller KB, Leingang H, et al. Efficacy of single-dose HPV vaccination among young African women: A randomized, controlled trial. NEJM. 2022; 387(8):713-723.
33. Moses F, Chirwa S, Phiri T. Scaling high-performance HPV DNA diagnostics via molecular platform sharing and self-sampling validation in Sub-Saharan Africa. Lancet Infect Dis. 2024; 24(9):1021-1033.
34. Paul P, Winkler JL, Bartolini RM. Single-visit screen-and-treat strategies with thermal ablation in low-resource clinics: A multi-center evaluation of programmatic loss to follow-up. PLOS Med. 2023; 20(11):e1004310.